Advanced Search
Tao Deming, . A Study of the Carcinogenesis Time and Incidence of Carcinoma in 46161 cases With Normal Hyperplastic Esophageal Epithelia[J]. Cancer Research on Prevention and Treatment, 1997, 24(3): 155-156.
Citation: Tao Deming, . A Study of the Carcinogenesis Time and Incidence of Carcinoma in 46161 cases With Normal Hyperplastic Esophageal Epithelia[J]. Cancer Research on Prevention and Treatment, 1997, 24(3): 155-156.
shu

A Study of the Carcinogenesis Time and Incidence of Carcinoma in 46161 cases With Normal Hyperplastic Esophageal Epithelia

  • Sichuan Yanting County Cancer Control Institute

More Information
    Graphical Abstract
    • Abstract
  • The carcinogenesis time and incidence of carcinoma of 46161 cases with nor-mal，slight hyperplastic and severe hyperplastic esophageal epithelia were studied. The results indicated that the average time of esohpageal carcinogenesis in the cases with severe hyperplastic，slight hyperplastic and normal esophageal epithelia were months，respectively;The incidence of esophageal carcinoma in the cases with severe hyperplastic，slight hyperplastic and normal esophageal epithelia were respectively.
    • FullText(HTML)
    • References (2)
  • 1陶 德明.盐亭20万人群食管癌普查报告.四川医学,1987,8(0):297.
    2林 培中，陆士新，张金生.食管癌前病变(食管上皮增 生)的研究概况.中华肿瘤杂志.1983.
    • Related Articles

  • Related Articles

    [1]WANG Jingyi, ZHONG Yuling, WU Lin. Immunotherapy for Advanced Non-small Cell Lung Cancer: Research Progress and Perspectives[J]. Cancer Research on Prevention and Treatment, 2024, 51(6): 409-418. DOI: 10.3971/j.issn.1000-8578.2024.24.0090
    [2]SU Chunxia, YU Xin. Advances of Immunotherapy for Non-small Cell Lung Cancer with Driver Gene Mutations[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 1-5. DOI: 10.3971/j.issn.1000-8578.2023.22.1033
    [3]CHENG Ying. Research Progress of Immunotherapy for Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2021, 48(8): 745-750. DOI: 10.3971/j.issn.1000-8578.2021.21.0472
    [4]LI Xiangmin, FAN Zaiwen. Challenges of Immune Checkpoint Inhibitors in Treatment of Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2019, 46(6): 556-560. DOI: 10.3971/j.issn.1000-8578.2019.18.1563
    [5]WU Li, WANG Yongsheng. Progress in Vaccines Against Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2016, 43(8): 721-727. DOI: 10.3971/j.issn.1000-8578.2016.08.015
    [6]LI Xiaofen, YUAN Ying. Individualized Treatment for Advanced Colorectal Cancer Patients Based on Molecular Characteristics[J]. Cancer Research on Prevention and Treatment, 2015, 42(09): 924-928. DOI: 10.3971/j.issn.1000-8578.2015.09.014
    [7]Liu Mingyue, Hou Guiqin, Gao Tianhui, Cui Yao, Li Xiaoyan, Zhou Yun. Efficacy of Pemetrexed Chemotherapy in Advanced Non-small Cell Lung Cancer with EGFR-TKI Resistence[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 713-715. DOI: 10.3971/j.issn.1000-8578.2012.06.025
    [8]ZHAN Yong-zi, HUANG Chang-jie, HUANG Jian-feng. Clinical Observation of Erlotinib in Treatment of Patients with Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(04): 461-462. DOI: 10.3971/j.issn.1000-8578.2010.04.025
    [9]LI Jing, LI Xin-qun, LI Jia-bang, et al, . Clinical Observations of Advanced Non-Small-Cell Lung Cancer Patients Treated with Continuous Infusion of Cisplatin and Oral Etoposide[J]. Cancer Research on Prevention and Treatment, 2000, 27(02): 144-145. DOI: 10.3971/j.issn.1000-8578.338
    [10]Liu Pu-xiang, . Short-term Effect of DDP-based combined chemotherapy in the treatment of advanced non-small cell lung cancer[J]. Cancer Research on Prevention and Treatment, 1995, 22(4): 247-248,246.

Catalog

    Get Citation
    PDF
    XML
    Article views (1118) PDF downloads (235) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：12169950 Visits today：28222

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return